The authors studied the effect of DNJ treatment on insulin signaling and Alzheimer’s disease markers in human insulin-resistant SK-N-SH neuroblastoma, underlying the usefulness of DNJ, which attenuated tau and amyloid pathologies by reversing neuronal insulin resistance. Here, INS is linked to early-onset autosomal dominant Alzheimer disease.